phase pharmacokinet polyethylen glycol solubl formul recombin prolong half-lif rout schedul administr patient comfort coval attach polyethylen glycol analog preclin data characterist biolog activ report phase maximum dose polyethylen glycol biolog activ prolong half-lif vivo sixty-six patient studi month polyethylen week minut maximum dose pattern toxic similar parent compound patient evid tumor regress partial remiss minor respons pharmacokinet data prolong half-lif recombin neutral antibodi studi suffici impetu ongo phase II studi polyethylen glycol 